These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


579 related items for PubMed ID: 19107973

  • 1. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
    Carotenuto P, Artsen A, Niesters HG, Osterhaus AD, Pontesilli O.
    J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
    [Abstract] [Full Text] [Related]

  • 2. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2).
    Duan XZ, He HX, Zhuang H.
    J Gastroenterol Hepatol; 2006 Jun; 21(6):970-6. PubMed ID: 16724980
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA, Quiroga JA, Subirá D, Castañón S, Esteban JM, Pardo M, Carreño V.
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [Abstract] [Full Text] [Related]

  • 4. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
    Zheng BJ, Zhou J, Qu D, Siu KL, Lam TW, Lo HY, Lee SS, Wen YM.
    J Viral Hepat; 2004 May; 11(3):217-24. PubMed ID: 15117323
    [Abstract] [Full Text] [Related]

  • 5. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
    Li RB, Chen HS, Xie Y, Fei R, Cong X, Fan CL, Wang SX, Wei L, Wang Y.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
    [Abstract] [Full Text] [Related]

  • 6. Activated plasmacytoid dendritic cells act synergistically with hepatitis B core antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response.
    Chen W, Zhang Z, Shi M, Chen L, Fu J, Shi F, Zhang B, Zhang H, Jin L, Wang FS.
    Clin Immunol; 2008 Nov; 129(2):295-303. PubMed ID: 18774748
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, Furutani M, Yamasaki T, Korenaga K, Yamashita S, Konishi T, Okita K.
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [Abstract] [Full Text] [Related]

  • 9. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM, Chen S, Al-Mahtab M, Abe M, Hiasa Y, Onji M.
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [Abstract] [Full Text] [Related]

  • 10. [Comparative study on dendritic cells stimulated with HBsAg or HBcAg in patients with chronic hepatitis B].
    Kang P, Luo SL, Li SC.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):250-2. PubMed ID: 17971936
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-alpha.
    Pontesilli O, van Nunen AB, van Riel D, Carotenuto P, Niesters HG, Uytdehaag FG, De Man RA, Osterhaus AD.
    Liver Int; 2004 Aug; 24(4):308-15. PubMed ID: 15287853
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B.
    Vassilopoulos D, Rapti I, Nikolaou M, Hadziyannis E, Hadziyannis SJ.
    J Viral Hepat; 2008 Nov; 15(11):817-26. PubMed ID: 18554242
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
    Sprinzl MF, Russo C, Kittner J, Allgayer S, Grambihler A, Bartsch B, Weinmann A, Galle PR, Schuchmann M, Protzer U, Bauer T.
    J Viral Hepat; 2014 Nov; 21(9):633-41. PubMed ID: 24251783
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Antiviral effect of human CTLs activated by HBsAg stimulated dendritic cells in vitro].
    Xing LH, Wang FS, Zhu CL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):365-8. PubMed ID: 15340554
    [Abstract] [Full Text] [Related]

  • 18. A study on interferon-gamma (IFN-gamma) response by T cells stimulated by hepatitis B virus core antigen.
    Paul S, Tabassum S, Islam MN.
    Bangladesh Med Res Counc Bull; 2004 Apr; 30(1):9-15. PubMed ID: 15376464
    [Abstract] [Full Text] [Related]

  • 19. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, Zhang SY, Li BS, Wang HF, Wu H, Lau GK, Fu YX, Wang FS.
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.